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ABSTRACT  
Background 
Self-management of inflammatory bowel disease is complex. Children and adolescents (CA) with 
inflammatory bowel disease (IBD) often have difficulty with managing aspects of their condition, resulting in 
treatment non-adherence and impaired psychosocial function. Self-management interventions are 
developed to help support patients and their parents/carers to effectively self-manage. The aim of this 
systematic review was to evaluate the efficacy of self-management interventions in children and 
adolescents with IBD.   
Methods 
The review was conducted in accordance with PRISMA guidelines. A systematic literature search of the 
following databases; Medline, Embase, Cochrane, CINAHL and PsychINFO was conducted to identify 
controlled trials of interventions aiming to enhance IBD self-management in CA.  Two reviewers screened 
articles for inclusion.  
Results 
Nine trials (eleven articles) met the inclusion criteria. Most were underpowered with seven recruiting fewer 
than 50 participants. The interventions aimed to enhance psychological wellbeing (n=5), medication 
adherence (n=3) or calcium intake (n=1). There was considerable heterogeneity in intervention content and 
outcomes assessment. Some benefits were reported in disease activity, adherence and psychological well-
being but findings were inconsistent.  
Conclusions 
Self-management is difficult for CA with IBD, however this review identified only a small number of 
interventions to support self-management, most of which were under-powered and only one that was 
conducted outside the US. Clinical consensus is required on which self-management activities should be 
recommended to patients and targeted in interventions and which core outcomes should be assessed. 
Adequately powered trials of interventions are required to identify how best to support self-management in 
CA with IBD. 
 
Keywords: Inflammatory Bowel Disease, Self-management, Children, Adolescents 
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INTRODUCTION  
The role that the patient plays in the day-to-day management of their disease is commonly referred to as 
self-management1, 2. Chronic disease self-management involves several tasks, including medical 
management, coping with the emotional impact of having a chronic disease and adapting one’s life roles to 
any limitations incurred by the disease3.  For children and adolescents (CA) with inflammatory bowel 
disease (IBD), medical management may include attending regular hospital appointments, taking 
medication, nutritional therapy, eating a balanced diet, staying hydrated, managing symptoms such as 
diarrhoea, pain and fatigue and the early detection of symptoms that can lead to a flare-up4, 5.  Role 
management may involve managing school and social relationships6.  Emotional management,  may 
include coping with stress and the potential embarrassment arising from having IBD7.   
 
Difficulties in IBD self-management experienced by CA include treatment non-adherence8, 9 and impaired 
psychosocial function10, 11. Proactive participation in IBD self-management, particularly among adolescents 
often aids a successful transition into adult care12.  In collaboration with healthcare professionals it is likely 
to improve treatment adherence13 and disease outcomes1,14.  
 
There is evidence that self-management interventions for CA can help to improve disease outcomes15, 16.  
Self-management interventions have been found to be effective for adults with IBD4 and also for CA with 
other chronic diseases16 such as asthma17, 18 and diabetes19.  This review aims to examine the efficacy of 
self-management interventions for CA with IBD. 
 
METHODS 
Studies meeting the following criteria, defined by Population, Intervention, Comparator, Outcome and study 
design (PICOS)20 were included.  
Inclusion Criteria: 
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Population: CA up to 19 years old with IBD, in line with the World Health Organization definition of 
adolescence21.  As many interventions for CA include parents/carers, trials that included parents/carers of 
CA with IBD were also eligible for inclusion.  
Intervention: Self-management interventions i.e. interventions that aimed to enhance participants’ ability to 
manage their condition and could include interventions to enhance medication adherence, lifestyle, diet, 
and coping with emotional and social aspects of living with IBD. 
Comparator: Treatment as usual, an alternative intervention or a waiting list comparator.   
Outcomes: Outcomes of interest included clinical, behavioural and psychosocial outcomes.   
Study design: Controlled trials (randomised and non-randomised). 
 
Exclusion Criteria: 
Studies were excluded if they were:  
 Articles that combined adults and CA with IBD or combined CA with IBD with other chronic diseases 
but did not report findings for CA with IBD separately. 
 Observational studies.  
 Written in languages other than English.  
 Trials published as conference abstracts, editorials, or letters and articles that had not been 
subjected to a formal peer review.  
 
Search strategy 
An electronic search was conducted across the following databases from inception to June 2016: Cochrane 
Review, CINAHL, Embase, Medline and PsychInfo.  Search terms used were: Inflammatory Bowel 
Disease; Ulcerative Colitis; Crohn’s Disease; Self-manag*; Patient education; Health Promotion; Lifestyle; 
Psycho*; Patient Adherence; Coping; Program*; Intervention; Therapy.  Relevant variations of search terms 
in the database thesauruses and MeSH terms were used. See Supplemental file 1 for the full search 
strategy.  
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Study selection 
Retrieved articles were imported into Endnote version X7 and duplicates were removed. Two reviewers 
(LT, KM) independently reviewed potentially eligible studies’ titles and abstracts and decided on the final 
inclusion of articles based on the full texts retrieved. 
 
Data extraction and management 
Relevant data were extracted from full text articles using an adapted Cochrane Data Extraction form22. Data 
were extracted on participant demographic and clinical characteristics, intervention characteristics and all 
reported outcomes. 
 
Assessment of risk of bias  
Study quality was assessed using the Cochrane "Risk of Bias" tool24. Trials were rated low, high or unclear 
across seven potential sources of bias: random sequence generation, allocation concealment, blinding of 
participants and personnel, blinding of outcome assessment, incomplete outcome data, selective reporting, 
and other bias. 
 
Analysis 
Owing to the heterogeneity of interventions and outcome measures, a meta-analysis was not considered 
appropriate and a narrative synthesis was conducted. 
 
ETHICAL CONSIDERATION 
As this is a systematic review of published data, ethical approval was not required. 
 
RESULTS 
A total of 808 references were identified, of which eleven articles, reporting nine trials 23, 25-30,31, 32 were 
included (Figure 1).   
 
Study and population Characteristics  
Study and population characteristics are shown in Table 1.  
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All except one of the trials were conducted in the USA23, 25-30, 32 Seven were randomized controlled trials 
(RCTs)23, 25-30 and two were non-randomized controlled trials31, 32. Overall, 521 CA participated in the trials 
and in most trials parents/carers were involved except for one that included adolescents only31.  A majority 
of trials were small with seven recruiting fewer than 50 participants23, 26-28, 30-32. Mean age ranged from 8.5-
15 years and more than 68% were Caucasian.  Most trials had an even gender distribution, except for two 
studies, one which consisted of 71.4% females30 and the other recruited females only to ensure a 
homogenous group32.   
Eight trials reported separately for IBD subtypes, in which the proportions with ulcerative colitis (UC) ranged 
from 17.5% - 33.3%, Crohn’s disease (CD) from 54% - 78.6% and Indeterminate Colitis (IDC) from 3%-
12.5%, although one trial did not specify the IBD types28.  Severity of IBD was reported in six studies, in 
which between 30-100% of participants had active disease25-28, 30, 32. 
One trial recruited only participants who had comorbid IBD and anxiety disorder28 and two trials recruited 
participants with IBD who met the criteria for depression29, 30.   
 
Intervention characteristics (See Table 2)  
Intervention Theoretical Framework and Content  
Five interventions were based on cognitive behavioural theory (CBT) and aimed to improve psychological 
wellbeing28,29, 30,31, 32.   
Three interventions used skills training to improve medication adherence25,26, 27.  
The final intervention taught behavioural strategies to increase dietary calcium intake23. 
Intervention Delivery Mode  
In only one trial, independent adolescent groups were conducted31. Three held CA sessions separately 
from the parent/carer sessions26, 28, 30, in three other trials parents/carers were involved in some CA 
sessions (i.e. at the beginning or end of intervention sessions)27, 29, 32 and in two the intervention was 
carried out as a family25, 26.  
 
Predominantly the interventions were delivered by clinical psychologists and psychology academics.  Most 
were delivered face-to-face23, 26-32, with one over the telephone25 and one online32.  The total number of 
sessions ranged from 4-13 and total duration ranged from 180 to 780 minutes.  
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Control/comparator groups 
The trials comprised a mix of control and comparator groups. These were: wait-list (n=4)25, 27, 31, 32; 
treatment as usual (n=2)26, 30; nondirective supportive control (described as offering social and emotional 
support through non-directive techniques) (n= 2)28, 29 and enhanced standard care (which included dietary 
counselling) (n=1)23.  Among the five CBT trials, two compared the intervention to other CBT treatments28, 
29.   
Risk of Bias  
Risk of bias was high for performance bias across all the studies but low for reporting bias, and attrition 
bias (Figure 2). Attrition rates ranged from 2.4% to 55% (median 12.25%). Selection and detection bias 
were low to moderate.  
 
Main Findings (See Table 3)  
Clinical Outcomes 
Disease Activity  
Two CBT interventions measured disease activity as an outcome 28, 29 .  A positive effect favouring CBT in 
reducing disease activity was found over time in,the larger trial (n=217) by Szigethy et al., 2014 29 but not 
the smaller trial (n=22) by Reigada et al.28.   
 
Symptoms 
One small trial of a coping skills intervention (n = 24) by McCormick et al.32 reported on abdominal pain 
outcomes.  There was no effect on abdominal pain, however somatization symptoms reduced over time in 
the intervention group but the between–group comparison was not significant. 
 
 
Behavioural Outcomes  
Medication Adherence  
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Three trials assessed medication adherence25-27 but findings were inconsistent.  Hommel et al. 2011 found 
a beneficial effect on adherence to one but not both of the assessed IBD medications27. Hommel et al. 
2012found a beneficial effect on one of the assessed medications, but only for patient-reported adherence 
whereas other measures of adherence – pill count, electronic monitor and parent-report – were not 
significant26.  Greenley et al. did not find an overall effect but reported an impact in a subgroup of 
participants aged over 16 years who were imperfect adherers at baseline25. 
 
Nutritional Adherence  
One trial, by Stark et al., that aimed to increase calcium intake found that a behavioural intervention was 
more effective than enhanced standard care23. 
 
Psychosocial Outcomes  
Five trials reported on psychosocial outcomes, all of which were evaluations of CBT interventions28-32.   
 
Health-related Quality of Life (HRQoL) 
Three trials assessed HRQoL. Szigethy at al. 2014 compared CBT to supportive non-directive therapy 
reported improvements over time but found no significant difference between the two conditions29.  
Greenley et al’s. problem-solving skills training study did not report between-group findings but found an 
effect in the intervention group after two weeks of intervention although none found at four weeks25.  In the 
third study by Grootenhuis et al.31, a subscale of HRQoL, (patient’s body image) detected a positive 
increase in the intervention group but no effect was found in other subscales.   
 
Global Mental Health  
A significant difference was found between the intervention and treatment as usual comparison groups in 
Szigethy et al’s 2007 trial that recruited CA with subsyndromal depression30.  However, Szigethy et al’s 
2014 trial comparing CBT with supportive non-directive therapy (SNDT) in participants with depression 
found no difference between treatments29.   
 
Anxiety and Depression  
9 
 
 
 
In a trial for participants with depression, Szigethy et al. 2014 found an improvement in both the CBT and 
SNDT groups but there were no differences between the groups in change over time and the trial did not 
include a usual care control group29,33.  In a trial of CBT in participants with subsyndromal depression, 
Szigethy et al. 2007 found an impact of CBT on a measure of depressive severity but not on the number of 
depressive symptoms immediately post-intervention.  The impact on depressive severity was not 
maintained at 6 or 12 month follow-ups30,34. 
 
Two trials measured anxiety; Reigada et al’s  trial of CBT for anxiety disorders saw a greater reduction in 
IBD-specific anxiety in the intervention group post-treatment and at 3 months follow-up 28 but there was no 
effect on trait anxiety (a predisposition to react to stressful situations with anxiety) in the other CBT trial by 
Grootehuis et al. 31.   
 
Self-worth  
Self-worth was assessed in one trial of CBT by Grootenhuis et al., in which the intervention group improved 
relative to the control group in global self-worth and physical self-perception but there was no effect found 
in five other sub-scales of the self-worth measure31.   
 
Behavioural-emotional problems 
One trial of CBT by Grootehuis et al. assessed parent reports of their child’s behavioural-emotional 
problems31. The intervention group reported a reduction in problems 6-8 months post baseline but between-
group findings were not reported. 
 
Coping 
In a trial of coping skills training by McCormick et al., parents reported more adaptive pain coping by their 
child in the intervention group compared to the control and over time. Parents over protectiveness and 
irrational cognitions about pain experienced by the adolescents were also significantly reduced32.  Parent 
outcomes were only reported in this one trial with a focus on changing their response or irrational thoughts 
about adolescents’ pain32.   
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Grootehuis et al. found that greater predictive control (optimism) about the further course of the disease 
was reported 6-8 months following CBT 31.  In another trial of CBT for subsyndromal depression, by 
Szigethy et al. 2007, an increase in perceived control was seen at 12-14wks30.   
 
Intervention acceptability  
Treatment satisfaction and acceptability was measured in four trials (.,Hommel et al. 2012., Hommel et al. 
2011, Reigada et al.)25-28 and ratings were mostly positive. However, adolescents in the Problem-Solving 
Skills Training intervention reported by Greenley et al were less satisfied with discussing issues over the 
phone compared to their parents25 and parents gave higher ratings than adolescents for two interventions 
by Hommel et al. to promote medication adherence26, 27. 
 
DISCUSSION  
To our knowledge, this is the first systematic review of self-management interventions for CA with IBD. The 
review identified nine trials, which mainly focused on improving either medication adherence or 
psychological wellbeing. There was considerable heterogeneity in both the intervention content and the 
outcomes measured. Most trials recruited very small samples and although some benefits were reported, 
findings were inconsistent. There remains a need to identify how best to support self-management in CA 
with IBD and to ensure that interventions are evaluated in adequately powered trials.  
 
Medication non-adherence is a common issue for adolescents with IBD8, 9. None of the three trials in this 
review that measured medication adherence were adequately powered. Although some positive outcomes 
were reported, these were not consistent across trials or assessment methods but were mainly found in 
sub-groups such as older non-adherent adolescents or the type of oral medication.  How best to improve 
medication adherence in CA with IBD therefore remains unclear.  The three interventions all used problem-
solving approaches to address barriers to adherence. A meta-analysis of interventions to promote 
adherence in paediatric chronic illnesses34 found that behavioural (e.g. problem-solving) and multi-
component interventions (usually behavioural plus another modality such as social support or family 
therapy) had the greatest effect. Therefore, given the under-powered nature of the existing trials in IBD, 
problem-solving interventions should not be dismissed as a potential approach for improving adherence.  A 
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study by Gray et al35 found that barriers to adherence in adolescents with IBD were moderated by 
anxiety/depressive symptoms therefore interventions that aim to improve medication adherence need to 
consider a broader approach that also incorporates strategies to identify and reduce symptoms of anxiety 
and/or depression.  
 
In terms of adherence to nutritional therapy, a beneficial increase in calcium food intake was achieved by 
training parents in behavior management strategies to encourage consumption of high calcium foods. No 
change was found in the comparison group that received education only, supporting the view that 
education as a standalone intervention is not sufficient to improve self-management in IBD4.  Although diet 
is an important aspect of IBD management, this was the only intervention that addressed any aspect of 
dietary self-management. Hommel et al36 have previously highlighted the need for further examination of 
dietary adherence in IBD. 
 
Psychological well-being is an important aspect of managing IBD13, 37.  Five trials focused on improving 
psychological wellbeing, however, several different outcomes were assessed and no single outcome 
measure was used in more than two trials. Some improvements were seen in depression in the short term 
however the lack of a usual care control group in one of the trials limits the validity of this finding.   A benefit 
was also seen for IBD-specific anxiety but not trait anxiety.  As the latter is considered a fairly stable 
personality characteristic, this is not unexpected and measuring disease-related anxiety may have been 
more appropriate. The interventions also showed some beneficial effect on adolescent self-esteem and 
coping whereas previously no efficacy was reported in a review of psychological interventions for adults 
with IBD38.  This suggests that being in a position of thinking positively and increasing perceived control that 
starts in adolescence may better enable patients to emotionally manage their chronic illness into adulthood.   
 
The effects on clinical outcomes such as disease activity were not well covered or reported in these 
studies.  One of the trials, the largest in the review, did find an impact of CBT on disease activity. It is 
important that self-management interventions should assess the relationship between any change in self-
management behaviours, psychosocial functioning and disease activity outcomes and also whether 
intervention efficacy is moderated by disease activity.  
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The interventions in this review did not address IBD self-management in the broad sense, as encompassed 
by the three tasks outlined by Corbin and Strauss3. The interventions focused on only a small part of 
medical management or emotional management but did not address how these factors may influence each 
other nor did they address any aspect of role management, such as managing IBD at school. This may be 
because there are no available guidelines regarding IBD self-management such as those that exist for CA 
with diabetes39 or asthma40. Given the complex nature of IBD self-management, it is important that clear 
guidelines should be drawn up on what patients and families need to do to effectively self-manage IBD. 
This will inform the content of future interventions to support patients and families in self-managing IBD, 
which could then be more consistent in what they address. Consensus also needs to be achieved on which 
outcomes are important so that there is greater consistency in the outcome measures that are used in 
evaluations of intervention efficacy.   
 
The important role that families play in helping CA to manage their IBD was recognised by the inclusion of 
families in most interventions. However, information on the parents/carers was sparse and only one trial 
reported parental outcomes. Parent stress has been found to be associated with poorer psychological 
adjustment in children with chronic illness41, therefore trials of interventions that involve parents should also 
assess the impact of the intervention on parents and to what extent this mediates the impact of the 
intervention on the CA.  Only one of the trials in this review recruited young children, for whom 
parents/carers would take most of the responsibility for IBD management. The intervention was effective in 
increasing calcium intake but research has not examined whether self-management interventions could 
improve other outcomes in young children with IBD or whether providing self-management support from a 
younger age could facilitate better self-management in adolescence.  
 
Most trials in this review were conducted in the USA. Epidemiological data indicate that the burden of IBD 
is increasing in many other parts of the world42, suggesting that IBD self-management interventions should 
be developed for and evaluated in these different healthcare systems.  
 
STRENGTHS AND LIMITATIONS OF THE REVIEW 
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We conducted a systematic and comprehensive literature search and the review was conducted using 
PRISMA guidelines.   
 
The review is limited by the underpowered studies and poor methodology of some trials that lacked a usual 
care control group.  Generally, the trials were underpowered to provide reliable intervention estimation of 
effectiveness. The heterogeneity of outcomes made it difficult to directly compare across trials. Inadequate 
analysis was apparent in some trials, for example reporting only results over time but not between groups.   
 
There was considerable heterogeneity in intervention structure, content, mode of delivery, and outcome 
measures, including diverse ways of reporting.  In order to establish how effective self-management 
interventions are in CA with IBD, and to better enable comparable analysis across trials, there needs to be 
a consensus on the content and assessment of self-management interventions for CA with IBD. 
 
CONCLUSION  
Identification of patient education interventions to improve self-management was rated as the top priority for 
IBD nursing and allied health professional research43 in a recent Delphi survey. This review identified some 
benefits of self-management interventions but there was a lack of well-designed, adequately powered trials.  
Most of the trials were conducted in recent years suggesting that self-management in CA with IBD is a 
relatively new and developing area. Further work is necessary to build clinical consensus on the self-
management activities that CA with IBD need to perform and the core outcomes to be assessed. 
Interventions should then be developed to target those key self-management activities and evaluated using 
the agreed core outcomes. 
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Table 1. Study population characteristics 
Author 
(Year);   
Country 
Study 
Design 
Sample 
Size 
Total (n) 
Total 
Attrition  
(%) 
Age Range; Mean Age 
(SD); Gender (%); 
Ethnicity (%) 
IBD type 
(%) 
Disease Severity (%) Reported Parents/Carers 
demographics can include; age, 
gender, marital status, education 
level, income 
Greenley et 
al (2015); 
USA25 
RCT  
 
I = 50 
C = 26 
n = 76  
14.5 
 
11-18; 14.54 (1.84);  
F (45);  
White/Caucasian (88) 
CD (72) 
UC (25) 
IDC (3) 
None/Remission (70);  
Mild (25); Moderate (5); 
Severe (0) 
Female Carers (93%) 
Grootenhuis 
et al (2009);  
Netherlands31 
NRCT I = 22 
C = 18 
n = 40 
20 12-18; I: 15.7 (1.5), C: 
15.4 (1.4);  
F (54);  
Ethnicity NR 
CD (69) 
UC (22.5)  
IDC (8.5) 
NR NR 
Hommel et al 
(2012); 
USA26 
RCT I = 20 
C = 21 
n = 41 
2.4 
 
11-17; 15.4 ± 1.5;  
M (50);  
White/Caucasian (90) 
CD (75) 
UC (17.5)  
IDC (7.5) 
CD: Inactive (28); Mild 
(55); Moderate/Severe 
(17). UC/IDC: Inactive 
(40); Mild (40); 
Mean age 46.2 ± 4.9; Married 
(87.5%);College degree (45%); 
Annual income: $100,001-
18 
 
 
 
Author 
(Year);   
Country 
Study 
Design 
Sample 
Size 
Total (n) 
Total 
Attrition  
(%) 
Age Range; Mean Age 
(SD); Gender (%); 
Ethnicity (%) 
IBD type 
(%) 
Disease Severity (%) Reported Parents/Carers 
demographics can include; age, 
gender, marital status, education 
level, income 
 Moderate/Severe (20) $125,000 
Hommel et al 
(2011); 
USA27 
RCT I = 7 
C = 8 
n = 15 
6.6 11-18; 14.89 ± 2.01;  
F (71);  
White/Caucasian (100) 
CD (78.6)  
UC (21.4) 
CD: Inactive (36.4); 
Mild (63.6) UC: Inactive 
(66.7); Moderate (33.3)  
Mean age 45.87 ± 3.79; Married 
(100%); College degree (43%)  
Annual income: $75,000-
$100,000 
McCormick 
et al (2010); 
USA32 
NRCT I = 29 
C = 11 
n = 31 
 55 
 
11-17; SD NR;  
F (100);  
White/Caucasian (92) 
CD (54.2)  
UC (33.3)  
IDC (12.5) 
IBD: Inactive (50); Mild 
(29); Moderate (21); 
Severe (0) 
NR 
Reigada et al 
(2015); 
USA28 
RCT I = 11 
C = 11 
0 
 
9-17; 13.65 ± 2.08;  
F (59);  
NR Active (100) Annual income:  
<$120,000 (59%) 
19 
 
 
 
Author 
(Year);   
Country 
Study 
Design 
Sample 
Size 
Total (n) 
Total 
Attrition  
(%) 
Age Range; Mean Age 
(SD); Gender (%); 
Ethnicity (%) 
IBD type 
(%) 
Disease Severity (%) Reported Parents/Carers 
demographics can include; age, 
gender, marital status, education 
level, income 
n = 22 White/Caucasian (68) > $120,000 (41%) 
Stark et al 
(2005); 
USA23 
RCT I = 19 
C = 19 
n = 38  
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5-12; I: 10.30 ± 2.38, C: 
10.64 ± 2.10;  
M (53);  
White/Caucasian (84.5) 
 
CD (75) 
UC (22) 
IDC (3) 
NR I: Mothers age 38.1 ± 3.9; Fathers 
age 40.3 ± 6.5.  
C: Mothers age 42.2 ± 6.0; 
Fathers age 43.8 ± 7.0.  
Annual income >$50,000 (66%) 
Szigethy et al 
(2014) &  
 
RCT I = 110 
C = 107 
n = 217 
18 
 
 
9-17; I: 14.3 (2.5), C: 14.3 
(2.3);  
M (47);  
CD (74) 
UC (26)  
 
NR NR 
20 
 
 
 
Author 
(Year);   
Country 
Study 
Design 
Sample 
Size 
Total (n) 
Total 
Attrition  
(%) 
Age Range; Mean Age 
(SD); Gender (%); 
Ethnicity (%) 
IBD type 
(%) 
Disease Severity (%) Reported Parents/Carers 
demographics can include; age, 
gender, marital status, education 
level, income 
 
(2015);  
USA29,33 
 
I = 82 
C = 79 
N =161 
 
10 
White/Caucasian (89) 
14.3 (2.4);  
M (46);  
White/Caucasian (88) 
 
CD (100) 
 
Szigethy et al 
(2007); USA 
& 
Thompson et 
al (2012);  
USA30,34 
RCT 
 
I = 22 
C = 19  
n = 41 
 
7.3 
 
11-17; 14.99 (2.01);  
F (51);  
White/Caucasian (78) 
 
CD (71%) 
UC (29%) 
IBD: Moderate/Severe 
(93%) 
College education (15%) and 
more than 4 years of college 
(60%). 
Annual income: $75,000 - 
$90,000 
 
C – Control group; CD – Crohn’s disease; I – Intervention group; IDC - Indeterminate Colitis; UC – Ulcerative colitis 
21 
 
 
 
 
Table 2. Intervention Characteristics 
First author  
Year  
Country 
Theoretica
l 
Framewor
k 
Structured 
or Tailored 
Intervention 
Group 
Intervention group (I) / Control or 
Comparison Group (C)  
 
Independent sessions 
or with family 
involvement  
No. of weekly 
Intervention 
Sessions. 
Duration  
(range). Mode 
of delivery  
Providers 
Greenley, 
2015, 
USA25 
Problem-
solving 
Tailored   I: Up to 4 sessions of phone based 
problem-solving skills training (PSST) 
tailored to address each family’s 
adherence barriers.   
  C: Wait-list Comparison Group 
Family sessions 2 or 4 
sessions; 
45–90 mins;  
Telephone 
Psychology graduates 
Grootenhuis, 
2009, 
Netherlands31 
CBT Structured   I: Psychoeducational group intervention 
to strengthen coping by teaching 
adolescents to actively use coping 
strategies. 
  C: Wait-list Control Group 
Independent 
Adolescent groups 
sessions.  
6 sessions;  
Duration NR;  
Face to Face 
NR 
22 
 
 
 
Hommel, 
2012, 
USA26 
 
NR   
 
Structured   I: Family-Based Group Behavioural 
intervention involved IBD education and 
organisation, goal setting, problem 
solving skills, positive reinforcement, 
adherence monitoring and on improving 
communication in the family.   
  C: Treatment as Usual Control Group 
Patients and parents 
meet independently in 
3 sessions. Family 
involvement in the last 
session only. 
4 sessions;  
60-90 mins; 
Face to Face 
Doctoral clinical 
psychologists, 
postdoctoral 
psychology fellows 
Hommel, 
2011, 
USA 27 
 
NR Tailored   I: Manualised individually tailored 
behavioural treatment included IBD 
education and organisational 
intervention, goal setting, problem 
solving skills, positive reinforcement, 
adherence monitoring and on improving 
communication  
  C: Wait-list Control Group  
Family sessions 
 
4 sessions; 
60-75 mins;  
Face to Face 
Doctoral clinical 
psychologists, 
postdoctoral 
psychology fellows 
McCormick, 
2010, 
USA32 
CBT 
 
 
Structured   I: Cognitive Behavioural Therapy aimed 
to effectively help patients cope with IBD 
symptoms, restructure maladaptive 
Independent parents 
and adolescent’s 
sessions with some 
1-day (6hrs),   
6 web-based 
and  
Clinical psychology 
graduates, clinical 
psychologist 
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 thoughts, use distraction techniques and 
communication skills. Parents training in 
providing helpful responses.   
  C: Wait–list Control Group 
family involvement. 30 mins online 
weekly chat 
sessions;  
Face to Face 
&  
Web Based 
 
 
Reigada,  
2015, 
USA28 
 
CBT  Tailored   I: CBT Treatment of Anxiety and 
Physical Symptoms related to IBD (TAPS 
+ IBD), patient self-care training was 
provided in IBD symptoms and anxiety 
management, in addition to relapse 
prevention strategies. The parent 
sessions involved a stepwise training in 
cognitive and behavioural strategies. 
  C: Nondirective Supportive Therapy 
Control Group offered social and 
emotional support only, no cognitive 
reappraisal, exposure or explicit 
Independent 
adolescent and parent 
sessions with some 
family involvement.  
I: 13 sessions,  
2 
posttreatment 
(monthly) 1-hr 
booster 
sessions.  
Three 1-hr 
parent 
sessions;  
 
C: 13 face-to 
face sessions 
Psychology doctoral 
students (n=6); 
postdoctoral clinical 
fellow (n=1) 
 
24 
 
 
 
instructions for practicing skills. 
Stark, 
2005, 
USA23 
 
NR Tailored   I: Behavioural Intervention, a stepwise 
approach was used in each parent 
session that focused on increasing 
calcium intake and training was provided 
in child behaviour management. Age-
appropriate entertaining educational 
activities were delivered to IBD- CA.   
  C: Enhanced Standard Care 
Comparison Group was an approximate 
of the dietary counselling that would be 
routinely available in a medical centre.  
Independent children 
and parent group 
sessions. 
  I: 6 sessions 
over an 8-
week period; 
C: 3 sessions 
over an 8-
week period; 
Approx. 60 
mins/session; 
Face-to-face 
sessions 
Ph.D. psychologist, 
postdoctoral fellow, 
research assistants 
(n=2) 
Szigethy, 
2014, 2015, 
USA 29,33 
CBT Structured 
& Tailored 
  I: CBT Primary and Secondary Control 
Enhancement Therapy-Physical Illness 
taught IBD-CA to recognize and 
challenge negative thoughts, weekly 
assignments were on behavioural 
activation and cognitive reframing.  
CA independent group 
sessions with family 
involvement at the end. 
  I&C: Up to 12 
sessions;  
45 mins; Face-
to-face and 
telephone. 
MSc social workers, 
psychology interns, 
psychologists, child 
psychiatry fellows, 
psychiatrist 
25 
 
 
 
Parent sessions were focussed on parent 
coaching and encouraging their children 
to use CBT skills.   
  C: CBT Standard Nondirective 
Treatment Control Group focussed on 
establishing rapport through listening and 
providing empathy, while encouraging 
youth to seek out resources for help.  
Szigethy, 
2007 & 
Thompson, 
2012, 
USA30,34 
CBT Structured     I: CBT Primary and Secondary Control 
Enhancement Therapy-Physical Illness 
(PASCET-PI) teaching skills via a 
manual to improve cognitions and 
behaviour in IBD-CA. Positive thinking, 
problem solving. 
    C: Treatment as Usual Comparison 
Group in addition received an information 
sheet on the signs of depression and 
treatment options available.  
Independent 
adolescent and parent 
sessions. 
  I: 9 to 11 
sessions;  
60 mins; Face-
to-face and 
telephone. 
Psychiatrists (n = 2), 
psychologists (n = 2), 
clinical social workers 
(n = 2) 
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Table 3. Main Findings 
Author 
(Year); 
Country 
Time points 
assessed 
Outcome Main Findings 
Outcome 
assessed  
Measuring Instrument   
Greenley et 
al (2015);  
USA25 
 
Baseline 
Post 2wks 
Post 4wks 
 
Behavioural -  
oral medication 
adherence 
MEMS Track Caps Between-group findings were not reported. 
No significant change in treatment adherence was found after two weeks of 
the intervention in the full sample or after four weeks in the group who 
received the extended intervention.  
A statistically significant increase in adherence after two weeks was found 
among a small subgroup (n=14), aged >16-18 years, (p < 0.05; d=0.95). 
HRQoL PedsQL Between-group findings were not reported. A significant improvement in 
HRQoL was found for the full sample after two weeks of intervention (t (66) 
= -2.83, p=0.006; d = 0.49) but no further change was found after four 
weeks in the group who received the extended intervention.  
Intervention 
Ratings - 
Intervention 
5-point Likert scale Participants were overall highly satisfied with the intervention, Youth mean 
rating (4.38) and Parent mean rating (4.20).  
Parents were more satisfied (4.48) with discussing issues over the phone 
28 
 
 
 
acceptability  compared to the Youth (3.90).  Youth felt that their medication taking 
behaviour improved (4.10) while the parents did not rate this as high (3.78).  
The lowest rating was in the information learned about child’s IBD and 
medication regime amongst parents (3.53).  
Grootenhuis 
et al (2009);  
Netherlands31 
 
Baseline 
Post 6wks  
Follow-up at 
6-8mth 
 
 
Psychosocial – 
Coping 
 
 
 
Self-esteem 
 
 
Anxiety  
 
Behavioural-
emotional 
problems 
 
Cognitive Control 
Strategies Scale  
The Intervention group reported greater optimism about the course of the 
disease (Predictive Control subscale), (p<0.01; β = 0.43). No effect on the 
Vicarious control or Interpretative control subscales. 
 
Self-perception Profile for 
Adolescents   
Intervention group reported more favourable self-perception for physical 
appearance (p<0.01; (β = 0.41) and global self-worth (p<0.01; β = 0.27) but 
no effect was found on the School competence, Social acceptance, Athletic 
competence, Behavioural conduct or Close friends subscales. 
 
State Anxiety  No intervention effect on anxiety. 
Parent reported - Dutch 
Child Behaviour Checklist 
Pre-post, Parents reported fewer behavioural-emotional problems about 
their children. (p<0.05) but no difference found between intervention and 
control. 
29 
 
 
 
 
HRQoL Daily Functioning Dutch 
Children’s AZL/TNO 
Quality of Life 
Questionnaire 
Effect on Body image favouring the Intervention group, (p<0.05; β = 0.39) 
but no effect on the Home functioning or Emotional functioning subscales or 
on Total functioning. 
 
Hommel et al 
(2012); 
USA26 
Baseline 
Post 4wks 
Behavior - 
Medication 
adherence 
 
Pill Count, Electronic 
Monitor Assessment, 
Parent-reported and Patient-
reported adherence 
assessment  
No significant differences between Intervention and Control from baseline to 
post-treatment assessments were found across pill count, electronic 
monitor and parent-reported adherence assessment. No significant 
difference was found between Intervention and Control on patient-reported 
adherence to 6-MP/azathioprine but there was a statistically significant 
effect of the intervention in patient-reported mesalamine adherence 
(Condition × Time interaction, F = 13.32, p< .05; δ = .69).  
 
Intervention 
Rating - 
Intervention 
acceptability  
7-point Likert scale.  Overall intervention was favourably accepted.  Parents highly liked the 
group format compared to adolescents (6.65 vs 5.70), they also thought that 
the group format was helpful (6.41 vs 5.75).  Parents used the behavioural 
skills more than adolescents (5.15 vs 4.79).   
30 
 
 
 
Both parents (5.41) and adolescents (5.25) highly rated the intervention for   
helping to improve adherence.  
Adolescents rated the convenience of attending the sessions lower (4.95) 
compared to their parents acceptability mean range of (5.88).  
The structure of the intervention (information, no. sessions, length and 
commitment time) had similar ideal ranges of high acceptability mean 
ratings between parents and adolescents. 
Hommel et al 
(2011); USA 
27 
Baseline  
Post 4wks 
  
Behavior - 
Medication 
adherence 
Pill Count  A statistically significant difference favouring the Intervention group was 
found in post intervention adherence to 6-MP/azathioprine (t=2.72, p<0.05), 
but not mesalamine (t=1.09, p=0.31) 
Intervention 
Rating - 
Intervention 
acceptability  
 
7-point Likert scale. Higher 
scores reflect higher 
satisfaction. 
Overall adolescents and parents rated the intervention as highly acceptable 
70-100%.  Parents rated the individualized format higher than adolescents 
(6.62 vs 5.86) and thought the format was helpful (6.50 vs 5.43).  Total time 
commitment for treatment was rated lower by adolescents (3.86) compare 
to parents (4.36). Parents used the behavioural skills more (5.15 vs 4.79) 
and felt that the treatment improved their child’s adherence (5.92 vs 5.43). 
The structure of the intervention (information, no. sessions, length and 
commitment time) had similar ideal ranges of high acceptability mean 
31 
 
 
 
ratings between parents and adolescents.  
McCormick et 
al (2010); 
USA32 
Baseline 
Post 6wks  
Follow-up at 
6mths 
Symptoms - 
Abdominal 
pain 
Abdominal Pain Index 
(API; Parent and Child 
Report)  
No effect of intervention on abdominal pain. 
   Psychosocial – 
Somatic 
Symptoms 
 
 
 
 
Parents 
cognitions 
 
 
Coping  
 
 
Child Somatization 
Inventory (CSI; Parent and 
Child Report) 
 
 
 
Adult Responses to 
Children’s Symptoms: 
Protect Scale (ARCS; 
Parent Report) 
 
Pain Coping Questionnaire 
 
Within group comparison: Statistically significant reduction in somatic 
symptoms from pre-post treatment. Parent-reported [F (1,12) = 7.48, 
p=0.009, n2p = 0.384] and Patient-reported [ F (1,12) = 8.32, p=0.007, n2p 
= 0.410] but no significant group differences.  
 
A significant reduction in overly protective parents of adolescents’ 
pain/symptoms pre/post at 6wks [ F (1,12) = 4.35, p=0.030, n2p = 0.266] and 
at 6mth follow-up [ F (1,8) = 7.69, p=0.010, n2p = 0.435]. 
 
 
Parent-reported PCQ approach scale had significantly higher scores 
compared to Control group at the end of the treatment [F (1,12) = 7.87, p = 
32 
 
 
 
 
 
 
 
 
 
 
 
 
Parents and 
adolescents’ 
cognitions 
about pain 
(PCQ; Parent and Child 
Report) 
 
 
 
 
 
 
 
 
Pain Catastrophizing Scale 
for Children (PCS-C) and 
Pain Catastrophizing Scale 
for Parents (PCS-P) 
0.005, n2p = 0.282] and in PCQ distraction [F (1,20) = 7.87, p = 0.005, n
2
p = 
0.282].  
Parent-reported significant improvement from pre/post 6wks in the 
Intervention group for their adolescents’ use of approach coping strategies: 
[ F (1,12) = 9.11, p=0.006, n2p = 0.432] and distraction techniques: [ F (1,12) 
= 6.44, p=0.013, n2p = 0.349] but there was no significance PCQ approach 
and distraction in the adolescent group.    PCQ emotional avoidance coping 
strategies was nonsignificant in the intervention however in the control an 
improvement was reported in adolescents [ F (1,12) = 4.95, p=0.027, n2p = 
0.355]. 
 
Significant reduction in parents own irrational cognitions about adolescent’s 
pain [ F (1,12) = 3.25, p=0.048, n2p = 0.213] but no significance in 
adolescent’s own view.  
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Reigada et al 
(2015); 
USA28 
Baseline 
Post 13wks  
Follow-up 
3mths 
  
Clinical – 
Disease 
activity 
Paediatric Ulcerative 
Colitis Activity Index and 
Paediatric Crohn’s Disease 
Activity Index 
No statistically significant effect of treatment condition or time was found.   
Psychosocial - 
Anxiety 
IBD-Specific Anxiety Scale  A significant reduction in Intervention compared to Control group at post 
intervention, (F (8.25), p=0.01, d = 1.21) and at 3-month follow-up (F (4.62), 
p=0.05, d = 0.75). 
 
 
Treatment 
expectancy 
and 
satisfaction 
Narratively reported Parents and patients reported moderate beliefs that the intervention can 
improve IBD and address nervousness.  Parents were very satisfied 
following treatment and would recommend the program, patients felt that 
the intervention helped them a lot and the therapist cared very much.  
Stark et al 
(2005); 
USA23 
Baseline 
Post 8wks 
Behavioural - 
Calcium intake 
Dietary food diaries Intervention group achieved significantly higher calcium intake than the 
control group (Condition by time interaction [F(1,30) =23.09, p< 0.001]  δ = 
0.44).  There was an average increase of 984mg/Ca/day in the intervention 
group compared to 274 mg/Ca/day in the control group.  At posttreatment 
34 
 
 
 
81% of Intervention participants achieved the 1500mg calcium per day 
compared to 19% of control participants, (χ2 = 12.50, p<0.001).  
 
Szigethy et al 
(2014) & 
(2015);  
USA29,33 
Baseline 
Post 3mths 
Clinical – 
Disease 
activity  
 
Paediatric Ulcerative 
Colitis Activity Index 
(PUCAI) and Paediatric 
Crohn’s Disease Activity 
Index 
(PCDAI)  
There was a statistically significant difference in reducing disease activity 
favouring CBT over time. (z = 2.01, p = 0.04)  
 
 
  Psychosocial - 
Depression 
The Children's Depression 
Rating Scale (CDRS-R) 
 
 
 
Kiddie-Schedule for 
Affective Disorders and 
Schizophrenia – Present 
Version (K-SADS-PL) 
No significant difference between interventions but an improvement was 
seen over time in both groups.   
In the CD sample, depressive severity improved over time for CBT (b = -
215.26; z = - 29.28; P < 0.0001) and SNDT (b = - 214.46; z = - 27.71; P < 
0.0001). 
 
At 3-months, 65.5% of the total sample no longer met the American 
Psychiatric Association's Diagnostic and Statistical Manual of Mental 
Disorders (DSM-IV-TR) criteria for depression. 
35 
 
 
 
 
  Global Mental 
Health  
Children's Global 
Assessment Scale  
No significant difference between interventions. Mean CGAS scores 
posttreatment, (CBT 65.83 versus SNDT 64.30) were consistent with 
minimal impairment on the CGAS scale.   
 
  HRQoL  Mean IMPACT-III Both therapies showed an improvement in HRQoL but no significant 
differences were found between treatments.   
 
Szigethy et al 
(2007); USA 
& Thompson 
et al (2012);  
USA30,34 
Baseline 
T2: 12 - 
14wks 
T3: 6mths 
T4: 12mths 
Psychosocial - 
Perceived 
control 
 
Perceived Control Scale 
for Children (PCSC) 
Significant positive effect of Intervention at T2 (t=2.13, p= 0.042).   
  Depressive 
symptoms 
Kiddie-Schedule for 
Affective Disorders and 
Schizophrenia – Present 
Version (K-SADS-PL) 
No significant. differences between groups and over time in syndromal 
depressive symptoms  
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   Children's Depression 
Inventory (CDI) and parent 
version (CDI-P)  
Statistically significant. CDI-CP difference between intervention and 
comparison group at T2 (t = 3.18, p = 0.003) however not significant at T3 
and T4. 
Statistically significant CDI-CP reduction in intervention from baseline to T4 
(p= 0.002) 
 
  Mental Health 
– General 
Mental 
functioning 
Children's Global 
Assessment Scale (CGAS) 
Global functioning significantly improved in the intervention group relative to 
the control group (F (3,35) = 3.70, p= .021) 
Significant higher scores in the intervention group at T2 and T3 (ps ≤ .05)  
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Figure 1. Preferred Reporting item for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram  
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Figure 2. Risk of bias for all included trials 
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Supplemental file 1. Search terms 
Search carried out in CINAHL.  Date of search: 02.06.2016 
# Query Results 
S25 S5 AND S9 AND S23 AND S24 33 
S24 AB intervention* OR AB program* OR AB therapy 419,305 
S23 S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 
OR S19 OR S20 OR S21 OR S22 
420,275 
S22 AB cope OR AB coping 22,126 
S21 (MM "Coping") 9,812 
S20 AB behavio#r* OR AB cognitive OR AB psycho* 227,807 
S19 AB compliance OR AB adherence 32,408 
S18 (MM "Patient Compliance") 10,075 
S17 AB lifestyle 18,088 
S16 (MM "Life Style") 6,212 
S15 AB "health promotion" 9,890 
S14 (MM "Health Promotion") 27,080 
S13 AB education 108,359 
S12 (MM "Patient Education") 20,015 
S11 AB "self care" OR AB self manag* 13,307 
S10 (MM "Self Care") 13,991 
S9 S6 OR S7 OR S8 210,330 
S8 AB child* OR AB adolescen* OR AB teen* OR AB young pe* OR AB 207,857 
41 
 
 
 
juvenile OR AB youth 
S7 (MM "Adolescence") 1,540 
S6 (MM "Child") 1,179 
S5 S1 OR S2 OR S3 OR S4 8,245 
S4 AB inflammatory bowel disease OR AB crohn* OR AB ulcerative colitis 3,937 
S3 (MM "Colitis, Ulcerative") 1,856 
S2 (MM "Crohn Disease") 2,811 
S1 (MM "Inflammatory Bowel Diseases") 2,412 
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Supplemental file 2. PRISMA 2009 Checklist  
Section/topic  # Checklist item  
Reported 
on page #  
TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or both.  1 
ABSTRACT   
Structured 
summary  
2 Provide a structured summary including, as applicable: background; objectives; 
data sources; study eligibility criteria, participants, and interventions; study 
appraisal and synthesis methods; results; limitations; conclusions and 
implications of key findings; systematic review registration number.  
2 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is already known.  3 
Objectives  4 Provide an explicit statement of questions being addressed with reference to 
participants, interventions, comparisons, outcomes, and study design (PICOS).  
3 
METHODS   
Protocol and 
registration  
5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web 
address), and, if available, provide registration information including 
registration number.  
Not 
registered 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and report 
characteristics (e.g., years considered, language, publication status) used as 
criteria for eligibility, giving rationale.  
3,4 
Information 
sources  
7 Describe all information sources (e.g., databases with dates of coverage, 
contact with study authors to identify additional studies) in the search and date 
last searched.  
4 
Search  8 Present full electronic search strategy for at least one database, including any 
limits used, such that it could be repeated.  
Suppl file 
1 
Study selection  9 State the process for selecting studies (i.e., screening, eligibility, included in 
systematic review, and, if applicable, included in the meta-analysis).  
5 
Data collection 
process  
10 Describe method of data extraction from reports (e.g., piloted forms, 
independently, in duplicate) and any processes for obtaining and confirming 
data from investigators.  
5 
Data items  11 List and define all variables for which data were sought (e.g., PICOS, funding 
sources) and any assumptions and simplifications made.  
5 
Risk of bias in 
individual 
studies  
12 Describe methods used for assessing risk of bias of individual studies 
(including specification of whether this was done at the study or outcome 
level), and how this information is to be used in any data synthesis.  
5 
Summary 
measures  
13 State the principal summary measures (e.g., risk ratio, difference in means).  Table 3 
Synthesis of 
results  
14 Describe the methods of handling data and combining results of studies, if 
done, including measures of consistency (e.g., I
2
) for each meta-analysis.  
5 
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